Cause of death, by non-communicable diseases, ages 5-14, male in Latvia
Latvia: Cause of death, by non-communicable diseases, ages 5-14, male was 35.8% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 5-14, male in Latvia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
Latvia recorded 35.8% for cause of death, by non-communicable diseases, ages 5-14, male in 2021.
Compared with earlier readings it is up 3.9% on the previous year and down 27.1% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Latvia peaked at 62.3% in 2015 and was at its lowest, 33.4%, in 2000.
Latvia ranks 88th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14, male in Latvia, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 33.4% | — |
| 2010 | 49.1% | +46.8% |
| 2015 | 62.3% | +26.9% |
| 2019 | 37.3% | -40.1% |
| 2020 | 34.5% | -7.7% |
| 2021 | 35.8% | +3.9% |
Latvia compared with similar countries
- Latvia's 35.8% is below the median for high income countries, which is 57.8%, 62% of the median. (58 countries reporting)
- Latvia's 35.8% is below the median for Europe & Central Asia, which is 54.5%, 66% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 33.4% | 33.4% | 33.4% | 1 |
| 2010s | 49.6% | 37.3% | 62.3% | 3 |
| 2020s | 35.1% | 34.5% | 35.8% | 2 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Latvia?
- Cause of death, by non-communicable diseases, ages 5-14, male in Latvia was 35.8% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Latvia?
- The highest recorded value was 62.3% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Latvia?
- The lowest recorded value was 33.4% in 2000.
- How does Latvia rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Latvia ranks 88th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Latvia?
- Over the last ten years it is down 27.1%. The long-run trend across the full record is flat.
- Where does this Latvia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.